NFE2L2 and chronic kidney disease: In light of a mainly decreased Nrf2 gene expression in advanced CKD [122], a bi-phasic, concentration-dependent effect of indoxyl sulfate in human CKD seems plausible, with Nrf2 activation in the lower concentration range and Nrf2 repression at high concentrations.